It is purely due to shipment of commercial molecules. Given you have a basket of molecules you supply- in some Quarters the molecules you supply to the innovator (APIs or intermediates) might not be there in other quarters. Simple reason:- innovator stocks up the supplies quantity. Which means for 2-3 Quarters same supply might not be there.
Thus, it’s a lumpy business. Growth should be looked at on yearly basis
Subscribe To Our Free Newsletter |